ヒアルロン酸の世界市場分析:製品別(単回注射、3回注射、5回注射)、用途別(皮膚充填剤、変形性関節症、眼科、膀胱尿管逆流)、原材料別(グレード[医薬グレード、化粧品グレード、食品グレード]、由来[動物ベース、動物以外ベース])、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Hyaluronic Acid Market Analysis by Product (Single Injection, Three Injection, Five Injection), by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), by Raw Materials (Grade [Pharmaceutical Grade, Cosmetic Grade, Food Grade], Source [Animal based, Non-Animal Based]), and Segment Forecasts to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends and Scope
4.1 Market Segmentation and Scope
4.1.1 Market driver analysis
4.1.1.1 Increasing geriatric population
4.1.1.2 Rising awareness and demand of anti-aging products
4.1.1.3 Increasing incidence rate of orthopedic and ophthalmic diseases
4.1.2 Market restraint analysis
4.1.2.1 Side-effects of hyaluronic acid injections
4.2 Penetration and Growth Prospects Mapping
4.3 Hyaluronic Acid Market PESTEL Analysis
4.4 Industry Analysis – Porter’s
4.5 Hyaluronic acid competitive landscape
4.5.1 Company market share analysis, 2015
4.5.2 Competitive landscape: Market position analysis (This segment would provide insights on the performance and position of key players operating in this market based on their product portfolio, segment financial performance, distribution network, regional presence and other strategic initiatives)
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
5.1 Global Hyaluronic Acid Market: Product Movement Analysis
5.2 Single Injection
5.2.1 Single injection market estimates and forecasts, 2013 – 2024 (USD Million)
5.3 Three injection
5.3.1 Three injection market estimates and forecasts, 2013 – 2024 (USD Million)
5.4 Five injection
5.4.1 Five injection market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 2: Application Estimates & Trend Analysis
6.1 Application Movement Analysis & Market Share, 2015 & 2024
6.2 Osteoarthritis
6.2.1 Osteoarthritis market estimates and forecasts, 2013 – 2024 (USD Million)
6.3 Ophthalmic
6.3.1 Ophthalmic market estimates and forecasts, 2013 – 2024 (USD Million)
6.4 Dermal Fillers
6.4.1 Dermal Fillers market estimates and forecasts, 2013 – 2024 (USD Million)
6.5 Vesicoureteral Reflux
6.5.1 Vesicoureteral Reflux market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 7 Market Categorization 3: Raw Material (by Grade) Estimates & Trend Analysis
7.1 Raw Material (by Grade) Movement Analysis & Market Share, 2015 & 2024
7.2 Pharmaceutical Grade
7.2.1 Pharmaceutical grade hyaluronic acid market estimates and forecasts, 2013 – 2024 (USD Million)
7.3 Cosmetic Grade
7.3.1 Cosmetic grade hyaluronic acid market estimates and forecasts, 2013 – 2024 (USD Million)
7.4 Food Grade
7.4.1 Food grade hyaluronic acid market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 8 Market Categorization 4: Raw Material (by Source) Estimates & Trend Analysis
8.1 Raw Material (by Source) Movement Analysis & Market Share, 2015 & 2024
8.2 Animal based
8.2.1 Animal based hyaluronic acid market estimates and forecasts, 2013 – 2024 (USD Million)
8.3 Non-animal based
8.3.1 Non-animal based hyaluronic acid market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter9 Market Categorization 5: Regional Estimates & Trend Analysis, by Product, Application, & Raw Material
9.1 Regional Movement Analysis & Market Share, 2015 & 2024
9.2 North America
9.2.1 North America hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.2.2 North America hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.2.3 North America hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.2.4 North America hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.2.5 U.S.
9.2.5.1 U.S. hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.2.5.2 U.S. hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.2.5.3 U.S. hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.2.5.4 U.S. hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.2.6 Canada
9.2.6.1 Canada hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.2.6.2 Canada hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.2.6.3 Canada hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.2.6.4 Canada hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.3 Europe
9.3.1 Europe hyaluronic acid market, by product, 2013 – 2024 (USD Million
9.3.2 Europe hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.2.3 Europe hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.2.4 Europe hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.3.5 Germany
9.3.5.1 Germany hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.3.4.2 Germany hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.3.5.3 Germany hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.3.5.4 Germany hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.3.6 UK
9.3.6.1 UK hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.3.6.2 UK hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.3.6.3 UK hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.3.6.4 UK hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.3.7 France
9.3.7.1 France hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.3.7.2 France hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.3.7.3 France hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.3.7.4 France hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.3.8 Italy
9.3.8.1 Italy hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.3.8.2 Italy hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.3.8.3 Italy hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.3.8.4 Italy hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.3.9 Russia
9.3.9.1 Russia hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.3.9.2 Russia hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.3.9.3 Russia hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.3.9.4 Russia hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.4.2 Asia Pacific hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.4.3 Asia Pacific hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.4.4 Asia Pacific hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.4.5 Japan
9.4.5.1 Japan hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.4.5.2 Japan hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.4.5.3 Japan hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.4.5.4 Japan hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.4.6 China
9.4.6.1 China hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.4.6.2 China hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.4.6.3 China hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.4.6.4 China hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.4.7 South Korea
9.4.7.1 South Korea hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.4.7.2 South Korea hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.4.7.3 South Korea hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.4.7.4 South Korea hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.5 Latin America
9.5.1 Latin America hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.5.2 Latin America hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.5.3 Latin America hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.5.4 Latin America hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.5.5 Brazil
9.5.5.1 Brazil hyaluronic acid market, by product ,2013 – 2024 (USD Million)
9.5.5.2 Brazil hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.5.5.3 Brazil hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.5.5.4 Brazil hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.5.6 Mexico
9.5.6.1 Mexico hyaluronic acid market, by product ,2013 – 2024 (USD Million)
9.5.6.2 Mexico hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.5.6.3 Mexico hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.5.6.4 Mexico hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.6.2 Middle East & Africa hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.6.3 Middle East & Africa hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.6.4 Middle East & Africa hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
9.6.5 South Africa
9.6.5.1 South Africa hyaluronic acid market, by product, 2013 – 2024 (USD Million)
9.6.5.2 South Africa hyaluronic acid market, by application, 2013 – 2024 (USD Million)
9.6.5.3 South Africa hyaluronic acid market, by raw material (grade), 2013 – 2024 (USD Million)
9.6.5.4 South Africa hyaluronic acid market, by raw material (source), 2013 – 2024 (USD Million)
Chapter10 Hyaluronic Acid Reimbursement Outlook
10.1 Reimbursement by Product
10.1.1 Gel One
10.1.2 EUFLEXXA
10.1.3 Synvisc-One
10.1.4 Supartz
10.1.5 Hyalgan
10.1.6 Monovisc
10.1.7 Orthovisc
10.1.8 Juvederm, Emervel, Restylane, Macrolane, Belotero, Filorga,Jalupro, Princess, Teosyal, Stylage, Filorga and others
10.2 Reimbursement by Region
10.2.1 U.S.
10.2.2 Canada
10.2.3 China
10.2.4 Japan
10.2.5 India
10.2.6 Brazil
10.2.7 South Africa
10.2.8 Europe
Chapter 11 Competitive Landscape
11.1 Allergan Inc
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Product benchmarking
11.1.4 Strategic initiatives
11.2 Sanofi
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.2.4 Strategic initiatives
11.3 Genzyme Corporation.
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Anika Therapeutics Inc.
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 Salix Pharmaceuticals
11.5.1 Company overview
11.5.2 Financial performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 Seikagaku Corporation
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.6.4 Strategic Initiatives
11.7 F.Hoffmann-La Roche Ltd.
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.7.4 Strategic initiatives
11.8 Galderma S.A
11.8.1 Company overview
11.8.2 Financial performance
11.8.3 Product benchmarking
11.8.4 Strategic initiatives
11.9 Zimmer Holdings Inc
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
11.10 Smith & Nephew plc
11.10.1 Company overview
11.10.2 Financial performance
11.10.3 Product benchmarking
11.10.4 Strategic initiatives
11.11 Ferring Pharmaceuticals Inc.
11.11.1 Company overview
11.11.2 Financial performance
11.11.3 Product benchmarking
11.11.4 Strategic initiatives
11.12 Lifecore Biomedical
11.12.1 Company overview
11.12.2 Financial performance
11.12.3 Product benchmarking
11.12.4 Strategic initiatives
11.13 HTL Biotechnology
11.13.1 Company overview
11.13.2 Financial performance
11.13.3 Product benchmarking
11.13.4 Strategic initiatives
11.14 Shiseido
11.14.1 Company overview
11.14.2 Financial performance
11.14.3 Product benchmarking
11.14.4 Strategic initiatives
11.15 Bloomage Freda Biopharm Co. Ltd
11.15.1 Company overview
11.15.2 Financial performance
11.15.3 Product benchmarking
11.15.4 Strategic initiatives
11.16 Maruha Nichiro, Inc
11.16.1 Company overview
11.16.2 Financial performance
11.16.3 Product benchmarking
11.16.4 Strategic initiatives


【レポート販売概要】

■ タイトル:ヒアルロン酸の世界市場分析:製品別(単回注射、3回注射、5回注射)、用途別(皮膚充填剤、変形性関節症、眼科、膀胱尿管逆流)、原材料別(グレード[医薬グレード、化粧品グレード、食品グレード]、由来[動物ベース、動物以外ベース])、セグメント予測
■ 英文:Hyaluronic Acid Market Analysis by Product (Single Injection, Three Injection, Five Injection), by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), by Raw Materials (Grade [Pharmaceutical Grade, Cosmetic Grade, Food Grade], Source [Animal based, Non-Animal Based]), and Segment Forecasts to 2024
■ 発行日:2016年8月24日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707412
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。